Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer

by Nalo Hamilton, David Austin, Diana Márquez-Garbán, Rudy Sanchez, Brittney Chau, Kay Foos, Yanyuan Wu, Jaydutt Vadgama, Richard Pietras
Published 2017-11-01

Biologic Roles of Estrogen Receptor-β and Insulin-Like Growth Factor-2 in Triple-Negative Breast Cancer

by Nalo Hamilton, Diana Márquez-Garbán, Vei Mah, Gowry Fernando, Yahya Elshimali, Hermes Garbán, David Elashoff, Jaydutt Vadgama, Lee Goodglick, Richard Pietras
Published 2015-01-01

Shift work in nurses: contribution of phenotypes and genotypes to adaptation.

by Karen L Gamble, Alison A Motsinger-Reif, Akiko Hida, Hugo M Borsetti, Stein V Servick, Christopher M Ciarleglio, Sam Robbins, Jennifer Hicks, Krista Carver, Nalo Hamilton, Nancy Wells, Marshall L Summar, Douglas G McMahon, Carl Hirschie Johnson
Published 2011-04-01

Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC

by Patricia A. Young, MD, Diana C. Márquez-Garbán, MD, Zorawar Singh Noor, MD, Neda Moatamed, MD, David Elashoff, PhD, Tristan Grogan, PhD, Tahmineh Romero, PhD, Hironobu Sasano, MD, PhD, Ryoko Saito, MD, PhD, Rebecca Rausch, PhD, Nalo Hamilton, PhD, Steven M. Dubinett, MD, Edward B. Garon, MD, Richard J. Pietras, MD, PhD
Published 2021-04-01